Girard Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-475
Closed -$90K 928
2018
Q3
$90K Buy
+475
New +$87.3K 0.02% 350
2017
Q4
Sell
-1,861
Closed -$381K 289
2017
Q3
$381K Sell
1,861
-15
-0.8% -$3.49K 0.08% 181
2017
Q2
$456K Buy
1,876
+391
+26% +$91.9K 0.1% 165
2017
Q1
$355K Buy
1,485
+492
+50% +$115K 0.09% 175
2016
Q4
$209K Buy
993
+118
+13% +$24.4K 0.06% 208
2016
Q3
$202K Buy
+875
New +$214K 0.07% 197

Other funds holding AGN

Girard Partners's AGN Position: Q4 2018 in Review

Girard Partners sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 475 shares — an estimated $90K sold.

Girard Partners first reported a position in AGN in Q3 2016 and held it in 6 quarters. The position peaked at $456K in Q2 2017. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Girard Partners reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Girard Partners sold 475 Allergan plc shares in Q4 2018, an estimated $90K.
  • Girard Partners first reported a position in Allergan plc in Q3 2016 and held it in 6 quarters.
  • Girard Partners's Allergan plc position peaked at $456K in Q2 2017.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Girard Partners's 13F filing for Q4 2018, filed 11 Feb 2019.